Vijay Pande on Leaving a16z’s $4B Bio Fund to Bet Small: ‘We’re Not Doing 30 Bets a Year’
Sunday, August 30, 2026 · first reported by CryptoRank
Vijay Pande departed Andreessen Horowitz's $4B Bio Fund to launch smaller, focused biotech investment vehicle.
- Fund
- Andreessen Horowitz Bio Fund
- People
- Vijay Pande
- Asset class
- Venture
- Geography
- North America
The summary and fields above are extracted from the published reports and can contain errors. The linked articles are the source of record.